Log in to save to my catalogue

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of h...

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of h...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4273700

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

About this item

Full title

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

Publisher

Paris: Springer Paris

Journal title

Annals of intensive care, 2014-07, Vol.4 (1), p.22-22, Article 22

Language

English

Formats

Publication information

Publisher

Paris: Springer Paris

More information

Scope and Contents

Contents

Background
Despite advances in supportive care, moderate-severe acute respiratory distress syndrome (ARDS) is associated with high mortality rates, and novel therapies to treat this condition are needed. Compelling pre-clinical data from mouse, rat, sheep and ex vivo perfused human lung models support the use of human mesenchymal stem (stromal)...

Alternative Titles

Full title

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4273700

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4273700

Other Identifiers

ISSN

2110-5820

E-ISSN

2110-5820

DOI

10.1186/s13613-014-0022-z

How to access this item